• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

几内亚无国界医生组织埃博拉项目中Xpert埃博拉检测法的可行性

Feasibility of Xpert Ebola Assay in Médecins Sans Frontières Ebola Program, Guinea.

作者信息

Van den Bergh Rafael, Chaillet Pascale, Sow Mamadou Saliou, Amand Mathieu, van Vyve Charlotte, Jonckheere Sylvie, Crestani Rosa, Sprecher Armand, Van Herp Michel, Chua Arlene, Piriou Erwan, Koivogui Lamine, Antierens Annick

出版信息

Emerg Infect Dis. 2016 Feb;22(2):210-6. doi: 10.3201/eid2202.151238.

DOI:10.3201/eid2202.151238
PMID:26812466
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4734513/
Abstract

Rapid diagnostic methods are essential in control of Ebola outbreaks and lead to timely isolation of cases and improved epidemiologic surveillance. Diagnosis during Ebola outbreaks in West Africa has relied on PCR performed in laboratories outside this region. Because time between sampling and PCR results can be considerable, we assessed the feasibility and added value of using the Xpert Ebola Assay in an Ebola control program in Guinea. A total of 218 samples were collected during diagnosis, treatment, and convalescence of patients. Median time for obtaining results was reduced from 334 min to 165 min. Twenty-six samples were positive for Ebola virus. Xpert cycle thresholds were consistently lower, and 8 (31%) samples were negative by routine PCR. Several logistic and safety issues were identified. We suggest that implementation of the Xpert Ebola Assay under programmatic conditions is feasible and represents a major advance in diagnosis of Ebola virus disease without apparent loss of assay sensitivity.

摘要

快速诊断方法对于控制埃博拉疫情至关重要,可促使及时隔离病例并加强流行病学监测。西非埃博拉疫情期间的诊断依赖于在该地区以外实验室进行的聚合酶链反应(PCR)检测。由于从采样到获得PCR结果的时间可能较长,我们评估了在几内亚的埃博拉防控项目中使用Xpert埃博拉检测法的可行性和附加价值。在患者诊断、治疗和康复期间共采集了218份样本。获得结果的中位时间从334分钟缩短至165分钟。26份样本埃博拉病毒检测呈阳性。Xpert检测的循环阈值始终较低,8份(31%)样本经常规PCR检测为阴性。还发现了一些后勤和安全问题。我们认为,在实际项目条件下实施Xpert埃博拉检测法是可行的,并且在埃博拉病毒病诊断方面取得了重大进展,且检测灵敏度无明显损失。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f23/4734513/d413866ca772/15-1238-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f23/4734513/270ddb25f730/15-1238-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f23/4734513/87cb3bace5ea/15-1238-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f23/4734513/b36b175c48a8/15-1238-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f23/4734513/d413866ca772/15-1238-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f23/4734513/270ddb25f730/15-1238-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f23/4734513/87cb3bace5ea/15-1238-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f23/4734513/b36b175c48a8/15-1238-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f23/4734513/d413866ca772/15-1238-F4.jpg

相似文献

1
Feasibility of Xpert Ebola Assay in Médecins Sans Frontières Ebola Program, Guinea.几内亚无国界医生组织埃博拉项目中Xpert埃博拉检测法的可行性
Emerg Infect Dis. 2016 Feb;22(2):210-6. doi: 10.3201/eid2202.151238.
2
Performance of the GeneXpert Ebola Assay for Diagnosis of Ebola Virus Disease in Sierra Leone: A Field Evaluation Study.GeneXpert埃博拉检测法在塞拉利昂诊断埃博拉病毒病中的性能:一项现场评估研究。
PLoS Med. 2016 Mar 29;13(3):e1001980. doi: 10.1371/journal.pmed.1001980. eCollection 2016 Mar.
3
Development and evaluation of a real-time RT-PCR assay for the detection of Ebola virus (Zaire) during an Ebola outbreak in Guinea in 2014-2015.2014 - 2015年几内亚埃博拉疫情期间用于检测埃博拉病毒(扎伊尔型)的实时逆转录聚合酶链反应检测方法的开发与评估
J Virol Methods. 2016 Feb;228:26-30. doi: 10.1016/j.jviromet.2015.11.007. Epub 2015 Nov 18.
4
Ebolavirus diagnosis made simple, comparable and faster than molecular detection methods: preparing for the future.埃博拉病毒的诊断变得简单、可比且比分子检测方法更快:为未来做好准备。
Virol J. 2018 Apr 23;15(1):75. doi: 10.1186/s12985-018-0985-8.
5
ReEBOV Antigen Rapid Test kit for point-of-care and laboratory-based testing for Ebola virus disease: a field validation study.雷斯顿埃博拉病毒抗原快速检测试剂盒用于埃博拉病毒病的现场即时检测和基于实验室的检测:一项现场验证研究。
Lancet. 2015 Aug 29;386(9996):867-74. doi: 10.1016/S0140-6736(15)61042-X. Epub 2015 Jun 25.
6
Analytical Performance Characteristics of the Cepheid GeneXpert Ebola Assay for the Detection of Ebola Virus.用于检测埃博拉病毒的赛沛GeneXpert埃博拉检测法的分析性能特征
PLoS One. 2015 Nov 12;10(11):e0142216. doi: 10.1371/journal.pone.0142216. eCollection 2015.
7
Clinical evaluation of the BioFire FilmArray BioThreat-E test for the diagnosis of Ebola Virus Disease in Guinea.在几内亚,对 FilmArray BioThreat-E 检测用于埃博拉病毒病诊断的临床评估。
J Clin Virol. 2017 Jul;92:20-24. doi: 10.1016/j.jcv.2017.04.015. Epub 2017 May 1.
8
Comparative Evaluation of the Diagnostic Performance of the Prototype Cepheid GeneXpert Ebola Assay.原型赛沛基因Xpert埃博拉检测方法诊断性能的比较评估
J Clin Microbiol. 2016 Feb;54(2):359-67. doi: 10.1128/JCM.02724-15. Epub 2015 Dec 4.
9
Clinical and epidemiological performance of WHO Ebola case definitions: a systematic review and meta-analysis.世界卫生组织埃博拉病例定义的临床和流行病学表现:系统评价和荟萃分析。
Lancet Infect Dis. 2020 Nov;20(11):1324-1338. doi: 10.1016/S1473-3099(20)30193-6. Epub 2020 Jun 25.
10
Development and Evaluation of a Rapid and Sensitive EBOV-RPA Test for Rapid Diagnosis of Ebola Virus Disease.用于埃博拉病毒病快速诊断的快速灵敏埃博拉病毒逆转录酶聚合酶链反应检测方法的开发与评估
Sci Rep. 2016 Jun 1;6:26943. doi: 10.1038/srep26943.

引用本文的文献

1
Proceedings from the Fourth Mesoamerican Symposium "Dr. Roberto Navarro López" on Emerging Zoonotic Disease and Arboviruses: Commenting Insights and Research Findings.第四届中美洲“罗伯托·纳瓦罗·洛佩斯博士”新兴人畜共患病和虫媒病毒研讨会会议记录:评论见解与研究发现
Res Rep Trop Med. 2025 Jul 31;16:65-89. doi: 10.2147/RRTM.S512767. eCollection 2025.
2
Maternal, fetal, and perinatal outcomes among pregnant women admitted to an Ebola treatment center in the Democratic Republic of Congo, 2018-2020.2018-2020 年刚果民主共和国埃博拉治疗中心孕妇的母婴和围产期结局。
PLoS One. 2023 Sep 8;18(9):e0286843. doi: 10.1371/journal.pone.0286843. eCollection 2023.
3

本文引用的文献

1
ReEBOV Antigen Rapid Test kit for point-of-care and laboratory-based testing for Ebola virus disease: a field validation study.雷斯顿埃博拉病毒抗原快速检测试剂盒用于埃博拉病毒病的现场即时检测和基于实验室的检测:一项现场验证研究。
Lancet. 2015 Aug 29;386(9996):867-74. doi: 10.1016/S0140-6736(15)61042-X. Epub 2015 Jun 25.
2
Evaluation of a point-of-care blood test for identification of Ebola virus disease at Ebola holding units, Western Area, Sierra Leone, January to February 2015.2015 年 1 月至 2 月,在塞拉利昂西部地区的埃博拉留观单位,评估即时护理点血液检测用于埃博拉病毒病的诊断。
Euro Surveill. 2015 Mar 26;20(12):21073. doi: 10.2807/1560-7917.es2015.20.12.21073.
3
Pooled Analysis of the Accuracy of Xpert Ebola Assay for Diagnosing Ebola Virus Infection.
Xpert Ebola assay 诊断埃博拉病毒感染准确性的汇总分析。
Biomed Res Int. 2021 May 17;2021:5527505. doi: 10.1155/2021/5527505. eCollection 2021.
4
Evaluating case definitions for Ebola virus disease.评估埃博拉病毒病的病例定义。
Lancet Infect Dis. 2020 Nov;20(11):1224-1226. doi: 10.1016/S1473-3099(20)30272-3. Epub 2020 Jun 25.
5
Symptom-Based Ebola Risk Score for Ebola Virus Disease, Conakry, Guinea.几内亚科纳克里埃博拉病毒病基于症状的埃博拉风险评分
Emerg Infect Dis. 2018 Jun;24(6):1162. doi: 10.3201/eid2406.171812.
6
Establishing Ebola Virus Disease (EVD) diagnostics using GeneXpert technology at a mobile laboratory in Liberia: Impact on outbreak response, case management and laboratory systems strengthening.在利比里亚的一个移动实验室使用GeneXpert技术建立埃博拉病毒病(EVD)诊断方法:对疫情应对、病例管理和实验室系统强化的影响
PLoS Negl Trop Dis. 2018 Jan 5;12(1):e0006135. doi: 10.1371/journal.pntd.0006135. eCollection 2018 Jan.
7
Reducing Uncertainty for Acute Febrile Illness in Resource-Limited Settings: The Current Diagnostic Landscape.减少资源有限环境下急性发热性疾病的不确定性:当前的诊断现状
Am J Trop Med Hyg. 2017 Jun;96(6):1285-1295. doi: 10.4269/ajtmh.16-0667.
8
Mortality among PCR negative admitted Ebola suspects during the 2014/15 outbreak in Conakry, Guinea: A retrospective cohort study.2014/15年几内亚科纳克里埃博拉疫情期间PCR检测呈阴性的埃博拉疑似住院患者的死亡率:一项回顾性队列研究。
PLoS One. 2017 Jun 30;12(6):e0180070. doi: 10.1371/journal.pone.0180070. eCollection 2017.
9
Operational Research during the Ebola Emergency.埃博拉疫情紧急时期的运筹学
Emerg Infect Dis. 2017 Jul;23(7):1057-1062. doi: 10.3201/eid2307.161389.
10
Bolstering Community Cooperation in Ebola Resurgence Protocols: Combining Field Blood Draw and Point-of-Care Diagnosis.加强埃博拉疫情复发应对方案中的社区合作:结合现场采血与即时诊断
PLoS Med. 2017 Jan 24;14(1):e1002227. doi: 10.1371/journal.pmed.1002227. eCollection 2017 Jan.
First trials for Ebola treatments announced.
埃博拉治疗方法的首次试验宣布。
Lancet. 2014 Nov 22;384(9957):1833. doi: 10.1016/s0140-6736(14)62043-2.
4
Clinical presentation of patients with Ebola virus disease in Conakry, Guinea.在几内亚科纳克里,埃博拉病毒病患者的临床表现。
N Engl J Med. 2015 Jan 1;372(1):40-7. doi: 10.1056/NEJMoa1411249. Epub 2014 Nov 5.
5
Clinical illness and outcomes in patients with Ebola in Sierra Leone.塞拉利昂埃博拉患者的临床疾病及转归
N Engl J Med. 2014 Nov 27;371(22):2092-100. doi: 10.1056/NEJMoa1411680. Epub 2014 Oct 29.
6
Feasibility of decentralised deployment of Xpert MTB/RIF test at lower level of health system in India.在印度卫生系统较低层级分散部署Xpert MTB/RIF检测的可行性。
PLoS One. 2014 Feb 26;9(2):e89301. doi: 10.1371/journal.pone.0089301. eCollection 2014.
7
Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial.在非洲基层医疗环境中使用即时 Xpert MTB/RIF 检测进行结核病检测的可行性、准确性和临床效果:一项多中心、随机、对照试验。
Lancet. 2014 Feb 1;383(9915):424-35. doi: 10.1016/S0140-6736(13)62073-5. Epub 2013 Oct 28.